John Renger is CSO at Cerevel Therapeutics Holdings, Inc. (CERE). They have made 17 open-market trades across 1 company since 2021, most recently 2024-08-01.
CIK 0001830363
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 17 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CERE | 8,531 | $384K |
Shares reported on the most recent Form 4, priced at the 2024-02-08 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CERE | SELL | 2024-02-07 | 2024-02-08 | $41.54 | $180K | -3.1% | -1.9% | -0.4% |
| CERE | SELL | 2022-11-01 | 2022-11-03 | $30.00 | $750K | +2.2% | -1.4% | +21.4% |
| CERE | SELL | 2022-10-04 | 2022-10-06 | $30.00 | $750K | -7.8% | -7.9% | +4.0% |
| CERE | SELL | 2022-08-10 | 2022-08-12 | $40.50 | $4.5M | -4.0% | -10.3% | -17.8% |
| CERE | SELL | 2022-08-05 | 2022-08-09 | $34.25 | $1.0M | -18.6% | -19.9% | -32.5% |
| CERE | SELL | 2022-07-20 | 2022-07-22 | $30.00 | $750K | +5.2% | +21.8% | -4.3% |
| CERE | SELL | 2022-07-05 | 2022-07-07 | $30.11 | $786K | -6.6% | +24.7% | +1.1% |
| CERE | SELL | 2022-04-13 | 2022-04-15 | $34.65 | $1.6M | -5.8% | -22.0% | -16.7% |
| CERE | SELL | 2022-03-29 | 2022-03-31 | $35.00 | $350K | -2.0% | -11.9% | -22.9% |
| CERE | SELL | 2022-03-16 | 2022-03-18 | $31.11 | $1.4M | +2.9% | -3.6% | -29.9% |
| CERE | SELL | 2022-03-09 | 2022-03-11 | $33.33 | $1.0M | -2.3% | +0.3% | -16.7% |
| CERE | SELL | 2022-03-02 | 2022-03-04 | $30.00 | $750K | +8.9% | +29.3% | -5.0% |
| CERE | SELL | 2022-02-09 | 2022-02-11 | $30.00 | $750K | -17.8% | -3.1% | -29.8% |
| CERE | SELL | 2021-12-23 | 2021-12-28 | $35.00 | $350K | -5.1% | -27.8% | +2.7% |
| CERE | SELL | 2021-12-21 | 2021-12-23 | $32.50 | $237K | -6.7% | -24.7% | -5.3% |
| CERE | SELL | 2021-12-15 | 2021-12-17 | $30.86 | $1.2M | +6.5% | -16.6% | +1.9% |
| CERE | SELL | 2021-11-10 | 2021-11-15 | $39.86 | $4.4M | -16.5% | -20.4% | -19.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.